| Literature DB >> 33367581 |
Xiuwen Wu1, Jie Wu1,2, Peige Wang3, Xueling Fang4, Yunsong Yu5, Jianguo Tang6, Yonghong Xiao7, Minggui Wang8, Shikuan Li3, Yun Zhang9, Bijie Hu10, Tao Ma11, Qiang Li12, Zhiming Wang13, Anhua Wu14, Chang Liu15, Menghua Dai16, Xiaochun Ma17, Huimin Yi18, Yan Kang19, Daorong Wang20, Gang Han21, Ping Zhang22, Jianzhong Wang23, Yufeng Yuan24, Dong Wang25, Jian Wang26, Zheng Zhou27, Zeqiang Ren28, Yuxiu Liu1, Xiangdong Guan29, Jianan Ren1.
Abstract
The Chinese guidelines for IAI presented here were developed by a panel that included experts from the fields of surgery, critical care, microbiology, infection control, pharmacology, and evidence-based medicine. All questions were structured in population, intervention, comparison, and outcomes format, and evidence profiles were generated. Recommendations were generated following the principles of the Grading of Recommendations Assessment, Development, and Evaluation system or Best Practice Statement (BPS), when applicable. The final guidelines include 45 graded recommendations and 17 BPSs, including the classification of disease severity, diagnosis, source control, antimicrobial therapy, microbiologic evaluation, nutritional therapy, other supportive therapies, diagnosis and management of specific IAIs, and recognition and management of source control failure. Recommendations on fluid resuscitation and organ support therapy could not be formulated and thus were not included. Accordingly, additional high-quality clinical studies should be performed in the future to address the clinicians' concerns.Entities:
Keywords: antimicrobial therapy; intraabdominal infection; nutrition; source control; treatment failure
Year: 2020 PMID: 33367581 DOI: 10.1093/cid/ciaa1513
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079